|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|
| Operating activities | ||
| Net increase (decrease) in net assets resulting from operations | ||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | ||
| Net realized (gain) loss | ||
| Net change in unrealized (appreciation) depreciation of investments | ||
| Net change in unrealized (appreciation) depreciation on Interest Rate Swap | ||
| Net change in unrealized (appreciation) depreciation on foreign currency translation | ||
| Interest and dividend income paid in kind | ||
| Net amortization of investment discounts and premiums | ||
| Amortization of deferred debt issuance costs | ||
| Amortization of original issue discount on debt | ||
| Changes in assets and liabilities: | ||
| Purchase of investments | ||
| Proceeds from disposition of investments | ||
| Decrease (increase) in interest, dividends and fees receivable | ||
| Decrease (increase) in due from broker | ||
| Decrease (increase) in receivable for investments sold | ||
| Decrease (increase) in prepaid expenses and other assets | ||
| Increase (decrease) in payable for investments purchased | ||
| Increase (decrease) in interest and debt related payables | ||
| Increase (decrease) in management fees payable | ||
| Increase (decrease) in income incentive fees payable | ||
| Increase (decrease) in accrued capital gains incentive fees | ||
| Increase (decrease) in Interest Rate Swap at fair value | ||
| Increase (decrease) in accrued administrative expenses | ||
| Increase (decrease) in accrued expenses and other liabilities | ||
| Net cash provided by (used in) operating activities | ||
| Financing activities | ||
| Draws on Credit Facility | ||
| Repayments of Credit Facility draws | ||
| Dividends paid to common stockholders | ||
| Payments of debt issuance costs | ||
| Repayment of 2022 Convertible Notes | ||
| Proceeds from issuance of 2025 Private Placement Notes | ||
| Repurchase of common shares | ||
| Net cash provided by (used in) financing activities | ||
| Net increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Supplemental cash flow information | ||
| Interest payments | ||
| Tax payments | ||
| Share issuance — conversion of 2022 Convertible Notes | ||
| Share issuance - stock distribution and reinvestment |
Loading...
